Dr. Richard Burt of Northwestern University wrapped up the first session with his presentation "Hematopoietic Stem Cell Transplantation for Multiple Sclerosis."

Dr. Jorg Gerlach. Dr. Gerlach, from the McGowan Institute for Regenerative Medicine at the University of Pittsburgh, presented: "Adult Autologous Skin Progenitor Cells for Wound Repair."

Dr. Michael Detamore of the University of Kansas presented: "Application of Biomaterials in Regenerative Medicine."

Dr. Dana Winegarner of the Rowe Neurology Institute provided an extensive summary of current clinical trials in Parkinson's Disease through his lecture.

Mark Weiss of Kansas State University, presented: "Where We Are with Cell Therapy for Graft Versus Host Disease."

Dr. David Prentice of the Family Research Council provided a very timely presentation on the regulatory considerations in stem cell therapy with particular attention to obtaining regulatory approvals and maintaining compliance with Federal, state, and local laws.

Dr. Rajasingh Johnson of the Cardiovascular Research Institute at the University of Kansas Medical Center, presented: "Induced Pluripotent Stem Cells from Adult Human Cells."

A special presentation was made by Kansas Governor Sam Brownback. Governor Brownback spoke briefly about the establishment of the Midwest Stem Cell Therapy Center at the University of Kansas Medical Center and the benefits it would bring to patients and their families in the region. He noted the advancements in the field of adult cell therapy and the importance of supporting the additional research needed to bring new cell therapies to those in need. He congratulated Dr. Dawn, the conference planning committee, and the conference faculty on bringing to fruition one of the goals of the MSCTC through continuing education of medical professionals and wished them continued success in future conferences.